entertainment -WSS

entertainment

author：fashion 2025-09-07 17:29:09 - browse：127

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Bristol 'take

Wikipedia

WSS

3 questions for the future of Biden's cancer moonshot

Prosecutors seek bail revocation for FTX founder Sam Bankman

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Pediatricians' group reaffirms support for gender

Medical mystery: When an infection after surgery isn’t what it seems

focus

entertainment

knowledge

In Memoriam: Notable people who died in 2023

AI can decode, harness the power of the humane immune system

Cancer drug shortages should be causing more outrage

A Q&A with the global head of Boehringer Ingelheim's innovation unit

The high cost of giving birth even with insurance

Chan Zuckerberg Biohub Chicago to focus on inflammation

Walensky prepares to leave CDC — and Congress — behind

Chemotherapy drug shortage eases slightly but still widespread

FDA approval of Sarepta Duchenne genetic therapy gives me hope

California Joshua trees severely burned in massive wildfire

hotspot

Slain Parkland victim's father speaks out following reenactment

Pharma needs to include young adults in clinical research

FDA panel signals lack of confidence in Amgen cancer drug data

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Pharma needs to include young adults in clinical research

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

focus

Wikipedia

knowledge

hotspot